iShares Neuroscience and HeaIBRNETF
13F holders, Q1 2026 (March 31)5holders +2
2new positions
0sold out
$32.96avg. 13F price*
At the end of Q1 2026, 5 institutions reported holding iShares Neuroscience and Hea (IBRN) in their 13F filings, up 2 from Q4 2025. 2 opened new positions and 0 sold out. The largest holders were BlackRock, Inc. ($1.5M), Steward Partners Investment Advisory, LLC ($707K) and Cwm, LLC ($5K).
- Company
- iShares Neuroscience and Hea
- CUSIP
- 46436E353
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $707K |
| Exits | 0 | $0 |
All 13F filers, Q4 2025 → Q1 2026: 21,462 shares bought and 41,025 shares sold, net −19,563 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 5 holders
| BlackRock, Inc. | 0.00% | Reduce -47.1% | 46,000 | $1.5M |
| Steward Partners Investment Advisory, LLC | 0.00% | New | 21,459 | $707K |
| Cwm, LLC | 0.00% | No change | 163 | $5K |
| UBS Group AG | 0.00% | Reduce -27.2% | 67 | $2K |
| Osaic Holdings, Inc. | 0.00% | New | 3 | $98 |
"% of holder's portfolio" is IBRN's weight in each manager's 13F, not the share of iShares Neuroscience and Hea the manager owns.